SanBio Company Limited provided consolidated earnings guidance for the first half and full year ending January 31, 2023. For the first half, the company expects operating loss of JPY 3,067 million, net loss attributable to owners of parent of JPY 3,169 million and net loss per share of JPY 61.19.

For the full year, the company expects operating loss of JPY 5,858 million, net loss attributable to owners of parent of JPY 5,997 million and net loss per share of JPY 115.79.